We are pleased to announce the release of the latest version of the ChEMBL database: chembl_04 In addition to the inclusion of new data from the primary scientific literature, three neglected-disease datasets have been deposited in the database: Plasmodium falciparum screening data from GSK, Novartis/GNF and St Jude Children's Research Hospital. These datasets can be identified on the basis of their src_id in the compound_records and assays tables. For more information, or to download the full deposited datasets, please visit the new ChEMBL-NTD website: https://www.ebi.ac.uk/chemblntd You can access the data via the ChEMBL database interface: https://www.ebi.ac.uk/chembldb/index.php Alternatively you can download the ChEMBL database (Oracle 9i, 10g, 11g, or MySQL) from our ftp site: ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/latest/ For details of upcoming webinars, please see: https://chembl.blogspot.com/search/label/Webinar
The 4th Annual Forum for SMEs is being held in Munich on October the 18th-19th 2010. The meeting has the aim of showcasing the facilities and support offered by EMBL-EBI for Small and Medium Enterprises (SMEs). The meeting also has a series of sessions from the European Patent Office (EPO). Further details can be found on the ENFIN website
We are running a brief web-based walkthrough of the ChEMBL-NTD deposited data and interface on Thursday 24th June 2010 at 3pm BST. If you are interested in receiving links to the meeting and a telephone number to call, please mail us . (Please, please, please use this link to mail, otherwise things easily get lost).
We are looking to appoint a part-time, home-based curator to cover biological drugs for the Open Access, Open Data drug discovery database ChEMBL. The role will require some previous experience of biological drug discovery and development, and a broad familiarity with the field. The biological drug portion of ChEMBL covers all classes of 'biotechnology' drugs, e.g. mAbs, aptamers, enzymes, peptides, solubilised receptors, etc . You will need to have your own computer and software (Excel, or OpenSource equivalent), bioinformatics experience, an investigative mind, and an eye for detail and thoroughness. If you are interested in this opportunity, mail for further details - please attach a current cv .
We're running two more ChEMBL webinars: A schema walkthrough, for those interested in dowloading the database and understanding the schema/data model - on Thursday 10th June at 3pm BST. Please click here to sign up. A demonstration of the ChEMBL web-interface and its features - on Thursday 17th June at 3pm BST. Please click here to sign up. We'll use webhuddle for the slides/demo. You don't need an account or any software, just a Java enabled web-browser. There will also be a separate number to dial into the audio.
It was clearly a slow news day in Swindon that day; but, in a way, wouldn't it be nice to live a place where this was big news. I for one, am glad the tortoise is OK ( google with the headline and you'll get the full, detailed story). Anyway, there are some significant publications in Nature this week on HTS screening and follow-up for Malaria screens (the papers are free content at the moment - Gamo et al , and Guiguemde et al . There are also some press releases for these papers and the public data release. We won't repeat the content of these formal things, but here provide some informal commentary... The magic data pixies here at EMBL-EBI have been working hard and we have loaded all the data into the latest release of our SAR database - ChEMBL04. The data is now live in the web interface , and the ftp download of the whole database will be in the near future (we are still optimising our production processes, so sorry that the data is available in the front-end b
Thanks for all the feedback so far on the interface and usability on the ChEMBL interface ; we have been working hard and are pleased to announce the release of a significantly enhanced interface. As regular users will rapidly see, there is a completely new tabbed interface structure, and many other enhancements scattered over many parts of the system. We also greatly appreciate the reporting of any errors in the data contained within the database - so please keep it up, your work benefits the entire community. We are also making progress on porting the chemical infrastructure to the fantastic OrChem Open Source chemistry plugin for Oracle databases. An Open Access publication for OrChem can be found here . Watch this space for more news.
The Industry Programme at the EMBL-EBI is currently planning a ca. 40 attendee workshop later in the year to cover informatics methods and resources used in the discovery of biological drugs. We currently plan to cover a review of historic biological drug discovery, review attrition for biological drugs, patent databases, mAb structure and engineering, enzyme replacement therapies and replacement therapies, methods to address immunogenicity, solubilised receptors, RNA and aptamer-based therapeutics, etc . Experts from industry and academia will present to the various subjects. We would greatly welcome ideas for inclusion in the workshop, volunteers for speaking, and so forth, also we would like to hear from you if you're potentially interested in attending.
There is a scheme to fund gifted Spanish (nationals or residents) researchers at EMBL - details are on the following link . The chEMBL group would welcome to host researchers in suitable areas (bioinformatics applied to drug discovery, chemogenomics, knowledge discovery from data for pharmaceutical data, etc. ) The deadline is May 29th 2010!
Chembl_03 is now available for download from the ftp site . We will also add new releases to the new BioTorrents network (probably complete once we get the hang of this new fangled Internets - many thanks to Egon for his input and advice!).